Association of hyperdiploidy with clinical and hematologic parameters of the entire study population
| . | Age (median, range), y . | Sex (male vs female), % . | Intact Ig, % . | Ig subtype (IgG vs IgA), % . | Light chain restricition (κ vs λ), % . | Bone marrow plasmacytosis, % (median, range) . |
|---|---|---|---|---|---|---|
| Hyperdiploid (n = 95) | 63 (40-87) | 51-49 | 89 | 79-21 | 57-43 | 12 (1-50) |
| Nonhyperdiploid (n = 331) | 60 (29-84) | 55-45 | 58 | 76-24 | 36-64 | 9 (1-46) |
| P | .04 | .5 | < .001 | .6 | < .001 | .007 |
| . | Age (median, range), y . | Sex (male vs female), % . | Intact Ig, % . | Ig subtype (IgG vs IgA), % . | Light chain restricition (κ vs λ), % . | Bone marrow plasmacytosis, % (median, range) . |
|---|---|---|---|---|---|---|
| Hyperdiploid (n = 95) | 63 (40-87) | 51-49 | 89 | 79-21 | 57-43 | 12 (1-50) |
| Nonhyperdiploid (n = 331) | 60 (29-84) | 55-45 | 58 | 76-24 | 36-64 | 9 (1-46) |
| P | .04 | .5 | < .001 | .6 | < .001 | .007 |